• Cardio Conferences
  • Cardio Quick Review
  • Cardio Calendar
  • Cardio Articles
  • Cardio Refresher
  • Cardio Case
  • Cardio Talks
  • Cardio ECG
  • Symposium
    Umbrella Heart FailureSymposium 1401Umbrella HypertensionUmbrella, Heart And StrokeUmbrella, CCSSymposium 1400
  • Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair

    September 18, 2022

    Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair

  • Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%

    September 13, 2022

    Umbrella: HF, Heart Failure with EF>40%

  • Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure

    September 13, 2022

    Umbrella: HF, Acute Decompensated HF

  • Umbrella: Heart Failure, Panel 2, Non-pharmacologic Approach to HF Management

    September 13, 2022

    Umbrella: HF, Non-pharmacologic Approach to HF

  • Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF

    September 13, 2022

    Umbrella: HF, Pharmacotherapy in HFrEF

  • ESC 2022 congress coverage: INVICTUS trial

    August 29, 2022

    ESC 2022: INVICTUS trial

  • ESC 2022 congress coverage: DELIVER trial

    August 28, 2022

    ESC 2022: DELIVER trial

  • ESC 2022 congress coverage: ALL-HEART trial

    August 28, 2022

    ESC 2022: ALL-HEART trial

  • ESC 2022 congress coverage: REVIVED trial

    August 28, 2022

    ESC 2022: REVIVED trial

  • ESC 2022 congress coverage: DANCAVAS trial

    August 27, 2022

    ESC 2022: DANCAVAS trial

  • ESC 2022 congress coverage: DANFLU-1 trial

    August 27, 2022

    ESC 2022: DANFLU-1 trial

  • ESC 2022 congress coverage: ADVOR trial

    August 27, 2022

    ESC 2022: ADVOR trial

  • ESC 2022 congress coverage: PERSPECTIVE trial

    August 27, 2022

    ESC 2022: PERSPECTIVE trial

  • ESC 2022 congress coverage: SECURE trial

    August 27, 2022

    ESC 2022: SECURE trial

  • ESC 2022 congress coverage: TIME trial

    August 27, 2022

    ESC 2022: TIME trial

  • A preview of ESC congress 2022

    August 26, 2022

    A preview of ESC congress 2022

  • Pulse Wave Velocity, a marker for arterial stiffness and a risk modifier for ASCVD

    August 24, 2022

    PWV in a nutshell

  • Hypertension and Hyperlipidemia Academy No. 10

    August 24, 2022

    H&H Academy No. 10

  • Antiplatelet Journal Scan

    August 6, 2022

    An Update on Antiplatelet Therapy

  • Vision: Vol. 2, Distal DVTs

    July 24, 2022

    The Second episode of Vision: distal DVTs

  • Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals

    July 19, 2022

    H&H Academy 10, for non-physician healthcare professionals

  • Vision: Vol. 1, What is Lp(a)?

    July 6, 2022

    The first episode of Vision: Lp(a)

  • Hypertension and Hyperlipidemia Academy, 9th session

    July 5, 2022

    9th session of H&H Academy

  • Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease

    June 26, 2022

    DCS 1401: Valvular heart disease

  • Daily Cardiology Symposium 1401, Day 2 Panel 3: Heart Failure

    June 26, 2022

    DCS 1401: Heart Failure

  • Daily Cardiology Symposium 1401, Day 2 Panel 2: Device therapy in cardiovascular diseases

    June 26, 2022

  • Daily Cardiology Symposium 1401, Day 2 Panel 1: Arrhythmia

    June 26, 2022

    DCS 1401: Arrhythmia

  • Young Cardiologist Award final review Panel

    June 26, 2022

    Young Cardiologist Award Panel

  • Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases

    June 26, 2022

    DCS 1401: Peripheral vascular diseases

  • Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis

    June 26, 2022

    DCS 1401: Venous thromboembolism (VTE) prophylaxis

  • Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD

    June 26, 2022

    DCS 1401: Revascularization in CAD

  • Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD

    June 26, 2022

    DCS 1401: Pharmacotherapy in CAD

  • Daily Cardiology Symposium 1401, opening remarks

    June 26, 2022

    DCS 1401: opening remarks

  • Hypertension and Hyperlipidemia Academy, 8th session

    May 22, 2022

    8th session of H&H Academy

  • Hypertension and Hyperlipidemia Academy, 7th session

    March 10, 2022

    7th session of H&H Academy

  • Cardiometabolic grand round: session 6

    March 9, 2022

    The 6th cardiometabolic grand round

  • Umbrella: Hypertension, hypertension and pregnancy

    March 8, 2022

    Umbrella: HTN, HTN and pregnancy

  • Umbrella: Hypertension, secondary hypertension

    March 8, 2022

    Umbrella: HTN, secondary HTN

  • Umbrella: Hypertension, Acute severe hypertension

    March 8, 2022

    Umbrella: HTN, acute severe HTN

  • Umbrella: Hypertension, Challenges in the diagnosis & management of HTN

    March 8, 2022

    Umbrella: HTN, diagnosis and management of HTN

  • Hypertension and Hyperlipidemia Academy, 6th session

    February 8, 2022

    6th session of H&H Academy

  • which prophylaxis? for whom? VTE prophylaxis panel discussion

    January 26, 2022

    Case-based panel discussion on VTE prophylaxis

  • Hypertension and Hyperlipidemia Academy: for nurses and medical assistants

    January 18, 2022

    H&H Academy: nurses and assistants

  • Hypertension and Hyperlipidemia Academy 5, a hybrid event

    January 7, 2022

    5th session of H&H Academy, online and onsite

  • Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke

    January 2, 2022

    Umbrella H&S: session 4, secondary prevention of stroke

  • Umbrella Heart and Stroke: session 3, Atrial fibrillation screening

    January 2, 2022

    Umbrella H&S: session 3, AF screening

  • Umbrella Heart and Stroke: session 2, carotid stenosis and stroke

    January 2, 2022

    Umbrella H&S: session 2, carotid stenosis

  • Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO

    January 2, 2022

    Umbrella H&S: session1, PFO

  • Hypertension and Hyperlipidemia Academy: 4th session

    December 26, 2021

    H&H Academy session 4

  • An introduction to a new series; HeartCast

    December 12, 2021

    HeartCast introduction

  • Ticagrelor Hub: when to use and which dose?

    November 28, 2021

    The dosage and indications of Ticagrelor

  • Cardiometabolic Grand round, Session 5

    November 21, 2021

    The 5th session of Cardiometabolic grand round

  • Primary prevention in dyslipidemia as the only cardiovascular risk factor

    November 4, 2021

    Dyslipidemia in primary prevention of low-risk patients

  • Late-breaking Science in Cardiovascular disease prevention

    November 2, 2021

    ESC 2021 cardiovascular prevention guideline lectures and discussion

  • Management of dyslipidemia in diabetic patients

    October 24, 2021

    DLP and T2DM: approach and management

  • DiaBeat: The Beating Heart of Diabetes (8th session)

    October 19, 2021

    8th Diabetes Masterclass for Cardiologists

  • The clinical landscape for Diabetes and Cardiovascular disease

    August 24, 2021

    T2DM and cardiovascular diseases: The clinical landscape

  • DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate

    August 14, 2021

    7th Diabetes Masterclass for Cardiologists

  • From optimal medical therapy to revascularization in CCS

    August 14, 2021

    Choosing the best therapeutic strategy in CCS

  • Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD

    August 14, 2021

    Antithrombotic regimens in CAD

  • Symptom matters: angina control in coronary artery disease

    August 14, 2021

    From surrogates to symptom control in CAD

  • Tailored Antithrombotic therapy for CCS patients

    July 25, 2021

    Best individual antithrombotic strategy in CCS

  • Marking the antiplatelet therapy maze in ACS

    July 12, 2021

    How to prevent atherosclerotic cardiovascular events

  • DiaBeat: The Beating Heart of Diabetes (6th session)

    June 24, 2021

    6th Diabetes Masterclass for Cardiologists

  • Cardiometabolic Grand Round: 4th session

    June 24, 2021

    Guideline-directed cardiovascular evaluations before surgery

  • Cardiovascular complications of T2DM: the preventive role of SGLT2Is

    June 20, 2021

    SGLT2Is and the prevention of cardiovascular complications in T2DM

  • DCS 1400: session 8, Valvular Heart disease

    June 16, 2021

    The eighth panel of DCS 1400: Valvular Heart disease

  • DCS 1400: session 7, VTE

    June 16, 2021

    The seventh panel of DCS 1400: Venous Thromboembolism

  • DCS 1400: session 6, Arrhythmia

    June 16, 2021

    The sixth panel of DCS 1400: Arrhythmia

  • DCS 1400: session 5, HF

    June 16, 2021

    The fifth panel of DCS 1400: Heart Failure

  • DCS 1400: session 4, ACS

    June 16, 2021

    The fourth panel of DCS 1400: Acute coronary syndrome

  • DCS 1400: session 3, CCS

    June 16, 2021

    The third panel of DCS 1400: Chronic coronary syndrome

  • DCS 1400: session 2, Diabetes for cardiologists

    June 16, 2021

    The second panel of DCS 1400: diabetes for cardiologists

  • DCS 1400: session 1, HTN and DLP

    June 16, 2021

    The first panel of DCS 1400: hypertension and dyslipidemia

  • DCS 1400: welcome remarks

    June 16, 2021

    The initial greetings of DCS 1400

  • How to reduce the atherosclerotic cardiovascular risk

    May 18, 2021

    A case-based Review on HTN and DLP management

  • The evolution of antiplatelet therapy in CAD: a 45 year journey

    May 10, 2021

    A brief history of anti-platelet therapy in CAD

  • Dual antiplatelet therapy in2021: Current recommendations

    May 10, 2021

    The latest updates on DAPT

  • DiaBeat: The Beating Heart of Diabetes (5th session)

    May 1, 2021

    5th Diabetes Masterclass for Cardiologists

  • DiaBeat: The Beating Heart of Diabetes (4th session)

    April 12, 2021

    4th Diabetes Masterclass for Cardiologists

  • DiaBeat: The Beating Heart of Diabetes (3rd session)

    April 12, 2021

    3rd Diabetes Masterclass for Cardiologists

  • DiaBeat: The Beating Heart of Diabetes (2nd session)

    April 11, 2021

    2nd Diabetes Masterclass for Cardiologists

  • DiaBeat: The Beating Heart of Diabetes (1st session)

    April 10, 2021

    1st Diabetes Masterclass for Cardiologists

  • PCSK9 inhibitors place in patients with cardiometabolic diseases

    March 16, 2021

    PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist

  • Cardiometabolic Grand Round (3)

    February 27, 2021

    A brief talk on DM medication challenges in patients with CVD

  • Introduction: Evolution of DOACs and their place in Guidelines

    January 21, 2021

    A brief report of Guidelines mentioned DOACs place in practice

  • 10th Case: Drug Drug Interactions

    January 21, 2021

    DOACs important interactions in clinical practice

  • To DOAC or Not to DOAC

    January 21, 2021

    Rapid review of oral anticoagulation practice in different clinical scenarios

  • 9th Case: Renal Insufficiency

    January 21, 2021

    OAC Management in Patients with CKD

  • 8th Case: Intracranial Bleed

    January 21, 2021

    OAC Choice in High Thrombotic Risk Patients after ICH

  • Seventh Case: Thrombocytopenia

    January 21, 2021

    Any Concerns for OACs Use in Patients with Thrombocytopenia

  • Sixth Case: Hepatic Impairment

    January 21, 2021

    OAC of choice in patients with hepatic impairment, any difference between DOACs?

  • Fifth Case: Stable ASCVD

    January 21, 2021

    Low dose Rivaroxaban in SIHD, COMPASS trial

  • Forth Case: Extreme Body Weights

    January 21, 2021

    OAC choice in patients with obesity or low body weights, any role for DOACs?

  • Third Case: AF & Artificial Heart Valves

    Third Case: AF & Artificial Heart Valves

    January 21, 2021

    OAC of choice in patients with artificial heart valves

  • Second Case: Cancer associated VTE

    January 21, 2021

    Anticoagulation of choice in patients with cancer, the importance of DDI

  • First Case: Elective PCI and AF

    January 21, 2021

    Antithrombotic regimen of choice in patients with AF undergoing elective PCI

  • Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape

    January 12, 2021

    Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

  • SGLT2 inhibitors in the treatment of HF: the future is bright?

    January 12, 2021

    Cardiologist Perspective on SGLT2 inhibitors

  • SGLT2 inhibition: A snapshot into their evolution

    January 12, 2021

    Endocrinologist Perspective on SGLT2 inhibitors

  • SGLT2 inhibition: Making waves in the heart failure landscape

    January 12, 2021

    Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

  • Residents’ Island: Abidi CVD Prevention Academy

    January 12, 2021

    Multidisciplinary approach to CVD Prevention

  • Cardiometabolic Grand Round (2)

    December 7, 2020

    A brief talk on DM medication challenges in patients with CVD

  • Cardiometabolic Grand Round

    Cardiometabolic Grand Round (1)

    November 1, 2020

    A brief talk on DM management in patients with CVD

  • How to Implement the Newest Diabetes Therapies in HF Treatment

    How to Implement the Newest Diabetes Therapies in HF Treatment

    October 29, 2020

    New insight from EMPEROR Reduced Trial

  • Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism

    October 29, 2020

    Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field

  • What we learned from ESC Congress about HTN Management

    October 22, 2020

    A Brief Discussion on HTN Management Pearls of ESC 2020

  • VTE Prophylaxis in Patients with COVID-19

    VTE Prophylaxis in Patients with COVID-19

    October 19, 2020

    Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)

  • What is new on NSTE-ACS Guideline

    ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion

    October 2, 2020

    Brief Discussion on the New ESC Guideline on NSTE-ACS

  • Diabetes and Cardiovascular Diseases

    Diabetes and Cardiovascular Diseases

    September 29, 2020

    On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

  • Smoking and the Heart the Struggle Continues.

    Smoking and the Heart the Struggle Continues

    September 29, 2020

    On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

  • The global challenge of obesity

    The weight of the world: The global challenge of obesity

    September 29, 2020

    On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

  • Ground-breaking research from ESC Congress 2020 (23)

    September 16, 2020

    Part Twenty-three: Trial Review, ELDERCARE-AF

  • Ground-breaking research from ESC Congress 2020 (22)

    September 16, 2020

    Part Twenty-Two: Trial Review, ATPCI

  • Ground-breaking research from ESC Congress 2020 (21)

    September 16, 2020

    Part Twenty-One: Trial Review, BPLTTC (CANCER)

  • Ground-breaking research from ESC Congress 2020 (20)

    September 16, 2020

    Part Twenty: Trial Review, POPULAR TAVI

  • Ground-breaking research from ESC Congress 2020 (19)

    September 16, 2020

    Part Nineteen: Trial Review, EXPLORER-HCM

  • Ground-breaking research from ESC Congress 2020 (18)

    September 16, 2020

    Part Eighteen: Trial Review, HOME-PE

  • Ground-breaking research from ESC Congress 2020 (17)

    September 16, 2020

    Part Seventeen: Trial Review, REALITY

  • Ground-breaking research from ESC Congress 2020 (16)

    September 16, 2020

    Part Sixteen: Trial Review, BPLTTC

  • Ground-breaking research from ESC Congress 2020 (15)

    September 16, 2020

    Part Fifteen: Trial Review, PARALLAX

  • Ground-breaking research from ESC Congress 2020 (14)

    September 16, 2020

    Part Fourteen: Trial Review, POPULAR CABG

  • Ground-breaking research from ESC Congress 2020 (13)

    September 16, 2020

    Part Thirteen: Trial Review, BAMI

  • Ground-breaking research from ESC Congress 2020 (12)

    September 16, 2020

    Part Twelve: Trial Review, EVAPORATE

  • Ground-breaking research from ESC Congress 2020 (11)

    September 16, 2020

    Part Eleven: Trial Review, DAPA-CKD

  • Ground-breaking research from ESC Congress 2020 (10)

    September 16, 2020

    Part Ten: Trial Review, DECLARE-TIMI

  • Ground-breaking research from ESC Congress 2020 (9)

    September 16, 2020

    Part Nine: Trial Review, RATE-AF

  • Ground-breaking research from ESC Congress 2020 (8)

    September 16, 2020

    Part Eight: Trial Review, COPS

  • Ground-breaking research from ESC Congress 2020 (7)

    September 16, 2020

    Part Seven: Trial Review, COLCOT

  • Ground-breaking research from ESC Congress 2020 (6)

    September 16, 2020

    Part Six: Trial Review, LoDoCo2

  • Ground-breaking research from ESC Congress 2020 (5)

    September 16, 2020

    Part Five: Trial Review, EAST-AFNET4

  • Ground-breaking research from ESC Congress 2020 (4)

    September 16, 2020

    Part Four: Trial Review, BRACE-CORONA

  • Ground-breaking research from ESC Congress 2020 (3)

    September 16, 2020

    Part Three: Trial Review; THEMIS, PAD

  • Ground-breaking research from ESC Congress 2020 (2)

    September 16, 2020

    Part Two: Trial Review, EMPEROR-REDUCED

  • Ground-breaking research from ESC Congress 2020

    September 16, 2020

    Congress Coverage: Introduction

  • Ground-breaking research from ESC Congress 2020

    Ground-breaking research from ESC Congress 2020

    September 10, 2020

    Brief Review of Main Trials Discussed in ESC Congress 2020

  • Shielding the Brain From Stroke

    Shielding the Brain From Stroke

    August 20, 2020

    A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke

  • Current Cardiology Practice of Antithrombotics in ASCVD

    Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion

    August 18, 2020

    Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease

  • Cardiometabolic Care Network

    Cardiometabolic Care Network

    July 16, 2020

    Interprofessional Collaboration Practice in Risk Management of ASCVD

  • Optimizing Heart Failure Care Throughout the Patient Journey

    Optimizing Heart Failure Care Throughout the Patient Journey

    June 25, 2020

    A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy

  • Low-dose Rivaroxaban in Management of PAD Patients

    June 23, 2020

    Insights from COMPASS & VOYAGER Trials

  • Rivaroxaban on Board for Chronic ASCVD

    June 23, 2020

    How DPI Found Its Way into Clinical Practice

  • Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients

    June 23, 2020

    Insights from COMPASS-PCI & COMPASS-CABG Trials

  • COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up

    May 12, 2020

    Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review

  • Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?

    May 10, 2020

    The role of medications in the pre and post prophylaxis against COVID-19

  • COVID and Cardiometabolic Challenges

    April 10, 2020

    Multidisciplinary approach to COVID-19 Cardiometabolic Complications

  • The evolving pandemic of COVID-19 and invasive cardiology consideration

    April 6, 2020

    Brief description of COVID-19 effect on approaching invasive strategies in patients with CVD

  • COVID-19 Cath Lab Implications

    March 29, 2020

    A frontline View from Italy

  • COVID-19 Sharing Facts, Not the Fear

    March 3, 2020

    Quick review on COVID-19 from an ID Perspective

  • Ischemic Cardiomyopathy to be Revascularized and How?

    Ischemic Cardiomyopathy to be Revascularized and How?

    November 19, 2019

    Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline

  • How to Select Appropriate Testing?

    How to Select Appropriate Testing?

    November 19, 2019

    Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline

  • Anti-ischemic Medications

    Anti-ischemic Medications

    November 19, 2019

    Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline

Follow US
  • admin@dailycardiology.ir
  • Telegram
  • Instagram
  • Contact us
  • Become a team member
Clinical Topics
    • Acute Coronary Syndrome
    • Ambulatory Blood Pressure Monitoring
    • Anticoagulation
    • Arrhythmia
    • Atrial Fibrillation
    • Cardiac Catheterization
    • Cardiac Imaging
    • Cardiac Surgery
    • Cardiometabolic Disease
    • Congenital Heart Disease
Clinical Topics
    • Coronary Angiography and Intervention
    • Deep Vein Thrombosis
    • Echocardiography
    • Electrocardiography
    • Geriatric Cardiology
    • Heart Failure
    • Hypertension
    • Infective Endocarditis
    • Noncoronary Invasive Procedures
    • Peripheral Arterial Disease
Clinical Topics
    • Pharmacotherapy
    • Prevention
    • Pulmonary Embolism
    • Pulmonary Hypertension
    • Sports and Exercise Cardiology
    • Stable ischemic Heart Disease
    • Valvular Heart Disease
    • COVID-19
    • CVD and disorders of other organs
    • Noncardiac Surgery

Copyright All rights reserved ©2021 Daily Cardiology Academy Team

Design By Tysiz